Table 2 Patient visits in the trial, data collection and outcome measures
Pre-screen | Baseline | 5 wk +5 d | 10 wk ± 7 d | 12 wk† ± 7 d | 24 wk ± 7 d | 52 wk ± 7 d | |
|---|---|---|---|---|---|---|---|
Diagnosis, inclusion & exclusion criteria | X | ||||||
Demographics | X | ||||||
Randomization | X | ||||||
Physical examination* | X | X | X | X | |||
Nerve conduction testing | X | X | |||||
Outcome questionnaires | X | X | X | X | X | ||
Rate of surgery | X | X | X | ||||
Sick-leave report | X | X | X | X | X | ||
Adverse events | X | X | X | X | |||
Study medication | X | ||||||
Concomitant medication | X | X | X | X |